News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Laura Bukavina: 8 doses of BCG vs. no treatment in high grade T1 bladder cancer
Laura Bukavina/X
Jan 23, 2025, 02:31

Laura Bukavina: 8 doses of BCG vs. no treatment in high grade T1 bladder cancer

Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X:

“JCOG1019 trial compared 8 doses of BCG vs. no treatment in HG T1 bladder cancer patients with pT0 reTURBT.

5-year RFS: 87% (BCG) vs. 82% (no treatment). Metastasis rates: 15% (BCG) vs. 21% (no treatment).

My Conclusion: 8 doses of BCG =insufficient; maintenance is critical.”

Laura Bukavina: 8 doses of BCG vs. no treatment in high grade T1 bladder cancer

Additional information

cancer Laura Bukavina OncoDaily Oncology
Special Coverage
Blog
Jan 23, 2025, 02:32
Tedros Adhanom Ghebreyesus: A productive discussion with President Samia Suluhu
Blog
Jan 23, 2025, 02:32
European School of Oncology - Attend the Fourth Online Course of the CCI4EU series on 28 February 2025
Blog
Jan 23, 2025, 02:32
Rob Winn: Eliminating the cancer burden and ensuring that the miracle medicine reaches every community
Blog
Jan 23, 2025, 02:32
Children's Cancer Institute - Cancer Australia consulted on the Draft National Framework for Genomics in Cancer Control
Blog
Jan 23, 2025, 02:32
Bruce Dunbar: Lung cancer is still the number 1 cancer killer
Blog
Jan 23, 2025, 02:32
Shaun Lintern: Thousands of NHS patients have died, gone blind or suffered serious injuries because of delays in their care
Blog
Jan 23, 2025, 02:32
Susan Galbraith: 5 key trends that have the potential to transform cancer care
Blog
Jan 23, 2025, 02:32
Christian Ntizimira: It is not the living who close the eyes of the dying, but the dying who open the eyes of the living
Blog
Jan 23, 2025, 02:32
Manoj Reddy: Honoring the legacy of Dr. Martin Luther King Jr.
Blog
Jan 23, 2025, 02:32
Muhammad Umair Mushtaq: Successful Use of a Midline Catheter for Leukapheresis in Immune Effector Cell Therapy
Blog
Jan 23, 2025, 02:32
The safety and effectiveness of sacituzumab govitecan with trastuzumab for HER2+ Metastatic Breast Cancer
Blog
Jan 23, 2025, 02:31
Laura Bukavina: 8 doses of BCG vs. no treatment in high grade T1 bladder cancer